Cofilin activation in peripheral CD4 T cells of HIV-1 infected patients: a pilot study by Wu, Yuntao et al.
BioMed  Central
Page 1 of 6
(page number not for citation purposes)
Retrovirology
Open Access Short report
Cofilin activation in peripheral CD4 T cells of HIV-1 infected 
patients: a pilot study
Yuntao Wu*1, Alyson Yoder1, Dongyang Yu1, Weifeng Wang1, Juan Liu1, 
Tracey Barrett2, David Wheeler2 and Karen Schlauch3
Address: 1Department of Molecular and Microbiology, George Mason University, Manassas, VA, 20110, USA, 2Clinical Alliance For Research & 
Education – Infectious Diseases, LLC, Annandale, VA, 22003, USA and 3Department of Genetics and Genomics, Boston University School of 
Medicine, Boston, MA, 02118, USA
Email: Yuntao Wu* - ywu8@gmu.edu; Alyson Yoder - ryoder@gmu.edu; Dongyang Yu - dyu2@gmu.edu; Weifeng Wang - wwangb@gmu.edu; 
Juan Liu - jliug@gmu.edu; Tracey Barrett - tbarrett@careidresearch.com; David Wheeler - dwheel423@verizon.net; 
Karen Schlauch - schlauch@bu.edu
* Corresponding author    
Abstract
Cofilin is an actin-depolymerizing factor that regulates actin dynamics critical for T cell migration
and T cell activation. In unstimulated resting CD4 T cells, cofilin exists largely as a phosphorylated
inactive form. Previously, we demonstrated that during HIV-1 infection of resting CD4 T cells, the
viral envelope-CXCR4 signaling activates cofilin to overcome the static cortical actin restriction. In
this pilot study, we have extended this in vitro observation and examined cofilin phosphorylation in
resting CD4 T cells purified from the peripheral blood of HIV-1-infected patients. Here, we report
that the resting T cells from infected patients carry significantly higher levels of active cofilin,
suggesting that these resting cells have been primed in vivo in cofilin activity to facilitate HIV-1
infection. HIV-1-mediated aberrant activation of cofilin may also lead to abnormalities in T cell
migration and activation that could contribute to viral pathogenesis.
Findings
Cofilin is a member of the actin-depolymerizing factor
(ADF) family of proteins [1] that play a central role in reg-
ulating actin dynamics [2,3]. The actin-severing and depo-
lymerization activities of cofilin are essential in
controlling cell polarity [4], cell motility [5] and cell divi-
sion [6,7]. In the human immune system, cofilin has also
been implicated in two hallmark activities of T cells,
namely chemotaxis and T cell activation [8]. In chemo-
taxis, directed cell movement towards chemoattractants is
controlled by localized cortical actin polymerization and
depolymerization, and cofilin is the driving force for pro-
moting the cortical actin dynamics [9]. In antigen-specific
T cell activation the reorganization of the cortical actin
plays a critical role in the formation of the immunological
synapse. Engagement of CD2 or CD28 receptors but not
TCR results in cofilin activation and its association with
the actin cytoskeleton [10]. Peptides that block cofilin
binding to actin result in severe defects in T cell activation
[11].
Cofilin activity is regulated through phosphorylation and
dephosphorylation at serine-3 by the simultaneous
actions of cofilin kinases and phosphatases [12-14]. Phos-
phorylated cofilin is unable to bind to F-actin; thus cofilin
is inactivated by phosphorylation and activated by
dephosphorylation [13,14]. The direct upstream kinases
that inactivate cofilin are the LIM kinases (LIMK1 and
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LIMK2) [15,16], whereas several serine phosphatases such
as slingshot, chronophin [17,18], PP1α and PP2A [19]
dephosphorylate and activate cofilin.
Recently, we [20] and others [21] have demonstrated that
in unstimulated resting CD4 T cells purified from the
peripheral blood, cofilin exists largely as the phosphor-
ylated form, implying that in the absence of chemotactic
stimulation or T cell activation, cofilin is largely inactive.
We have also suggested that this restricted cofilin activity
in resting T cells inhibits the cortical actin dynamics, hin-
dering viral post-entry migration. Thus, HIV-1 hijacks
chemokine receptor signalling through CXCR4 to trigger
the activation of cofilin. This process increases the cortical
actin dynamics, facilitating viral nuclear migration
[20,22].
Given the fact that in infected patients, CD4 T cells are
chronically exposed to gp120, we decided to investigate
the outcome of persistent gp120 stimulation on cofilin
phosphorylation. To address this question, we initially
used resting CD4 T cells purified from HIV negative
donors and stimulated them with HIV-1 or gp120 for
extended periods of time. We incubated cells with the
virus for several hours up to 24 hours instead of minutes.
Persistent stimulation of a receptor has been known to
affect down-stream targets differently than transient stim-
ulation [23]. As shown in Figure 1A, we observed cycles of
cofilin phosphorylation and dephosphorylation with the
prolonged treatment. These data suggest that persistent
stimulation with HIV will likely have a lasting impact on
the cofilin activity. We also repeated this experiment using
purified gp120 and observed persistent cofilin dephos-
phorylation (Figure 1B). The variation in cofilin responses
between HIV particles and gp120 may be related to differ-
ences in dosage or gp120 conformation. HIV particles
carry the gp120 trimer on the surface, whereas the purified
gp120 protein we used is a monomer. This is reminiscent
of the CD40 ligand (CD40L) in its distinctive signalling
properties as a trimer or as a monomer [24]. The strength
and persistence of CD40L stimulation dictate the capacity
of dendritic cells either to migrate to draining lymph
nodes or to secrete locally inflammatory cytokines [24].
Based on these results, we also hypothesized that activa-
tion of cofilin may also occur in the resting CD4 T cells of
HIV-1-infected patients, considering that these resting T
cells are chronically exposed to gp120 during the course of
infection, and that even in patients on HAART, latently
infected cells persist and low levels of viral replication take
place [25-27]. Additionally, the threshold for coreceptor
activation of signalling has been shown to be as few as two
HIV virion particles [28]. Thus, we set up a small-scale
pilot study to probe cofilin activity in resting cells purified
from HIV-1-infected and uninfected subjects. Peripheral
blood resting CD4 T cells from eight infected (Additional
file 1) and ten uninfected subjects were purified by nega-
tive depletion, unstimulated and then analyzed by immu-
noblotting for both phospho-cofilin and total cofilin. As
shown in Figure 2, in the resting CD4 T cells of uninfected
subjects, cofilin exists primarily in its inactive phosphor-
ylated form in the absence of chemotactic stimulation or
T cell activation [20,21] (Figure 2C). In contrast, in HIV
positive patients, significantly lower ratios of phospho-
cofilin to total cofilin (HIV-, 1.142; HIV+, 0.535; p =
0.002) (Figures 2A and Figure 2B) were observed, suggest-
ing a significant shift towards cofilin activation. These
results were further confirmed by NEPHGE-western blot
to measure the absolute ratio of phospho-cofilin to active
cofilin (Figures 2C, Figure 2D). Again, we observed con-
siderably lower ratios of phospho-cofilin to active cofilin
in HIV-1-infected patients, confirming the upregulation
of cofilin activity in resting CD4 T cells of HIV-1-infected
patients. Given the great extent of cofilin activation and
the fact that a majority of resting CD4 T cells in patients
are not infected (0.2–16.4 HIV-latently infected cells per
106 resting CD4 T cells [29]), these data imply a global
activation of cofilin in resting CD4 T cells, not just those
infected by HIV-1. Therefore, indirect mechanisms, such
as contact with viral or cell-free gp120 or chronic immune
Activation of cofilin in resting CD4 T cells cultured in vitro  and stimulated with HIV-1 and gp120 Figure 1
Activation of cofilin in resting CD4 T cells cultured in 
vitro and stimulated with HIV-1 and gp120. Resting 
CD4 T cells were purified from uninfected donors by anti-
body-mediated negative depletion using Dynalbeads as previ-
ously described [20]. Cells were cultured overnight in the 
absence of cytokines or activation, and then stimulated with 
HIV-1 (10 ng p24) (A) or with gp120 (50 nM) for various 
times at 37°C as indicated. Stimulated cells were lysed and 
analyzed by western blot using antibodies against the phos-
phorylated cofilin (P-cofilin) or total cofilin or GAPDH for 
controls.
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Activation of cofilin in resting CD4 T cells of HIV-1-infected patients Figure 2
Activation of cofilin in resting CD4 T cells of HIV-1-infected patients. (A) Resting CD4 T cells were purified by anti-
body-mediated negative depletion using Dynalbeads. Cells purified from HIV-1-infected and uninfected donors were cultured 
overnight in the absence of cytokines or activation, and then lysed and analyzed by western blot using antibodies against P-cofi-
lin or total cofilin. The relative ratios of P-cofilin to total cofilin were measured and plotted. HIV-1-infected patients had statis-
tically-significant lower ratios of P-cofilin/cofilin (0.535 versus 1.142, p = 0.002), suggesting higher levels of active cofilin. For 
statistic analysis, a two-tailed Student's t-test on the means resulted in a p-value of p = 0.002. At a pre-determined significance 
level of 0.05, this shows that the difference in the mean ratios of the two sample groups is statistically significant. A standard 
power computation showed that the t-test was very well powered (95.2%) for this study. (B) Shown are the longer exposures 
of the western blots used in (A). The results were confirmed by NEPHGE-western blot to directly separate P-cofilin to active 
cofilin, and then probed with an anti-cofilin antibody [20]. Shown are the absolute ratios of P-cofilin to active cofilin in HIV-1 
negative donors (C) and HIV-1-infected donors (D).
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activation, may be responsible for the activation of cofilin
in resting CD4 T cells in patients. Importantly, the cofilin
activation observed is not a result of general T cell activa-
tion, since the population of CD4 T cells purified from
patients is quiescent, judged by the lack of activation
markers such as HLA-DR or CD69 on the cell surface (Fig-
ure 3), similar to a previous observation [30]. This also
appears to be consistent with our previous demonstration
that although stimulation with gp120 can trigger cofilin
activation, it does not activate resting T cells [20]. Our
data also demonstrate that in the peripheral blood of
infected patients, resting CD4 T cells have largely been
altered or primed, at least in cofilin activity, to facilitate
HIV-1 infection. Nevertheless, the small patient popula-
tion as well as lack of multiple controls and long-term fol-
low up studies did not permit us to conclude that the
cofilin activation observed is necessarily the result of
chronic gp120 exposure, although gp120 has a demon-
strated ability to trigger cofilin activation in vitro [20]. Fur-
ther large-scale studies are needed to address this
correlation and other critical questions such as the possi-
ble relationship between cofilin activation and disease
progression. Future studies are also required to determine
whether the status of cofilin correlates with drug treat-
ment. Our previous in vitro study [20] and this small-scale
pilot investigation certainly serve as a rationale for future
clinical studies.
HIV-1-mediated aberrant activation of cofilin in resting
CD4 T cells may affect normal T cell migration and T cell
activation. In the human immune system, cofilin is
directly involved in chemotaxis and T cell activation. For
Lack of detection of T cell activation markers on the surface of resting CD4 T cells from HIV-1-infected and uninfected donors Figure 3
Lack of detection of T cell activation markers on the surface of resting CD4 T cells from HIV-1-infected and 
uninfected donors. Resting CD4 T cells were purified by antibody-mediated negative depletion using Dynalbeads. Cells puri-
fied from HIV-1-infected and uninfected donors were cultured overnight in the absence of cytokines or activation, and then 
stained for surface expression of HLA-DR or CD69. Shown are flow cytometry analyses of cells stained with a PE-labelled anti-
human HLA-DR antibody (A and C, right panel) or a similarly labelled isotype control antibody (A and C, left panel). Cells were 
also stained with a PE-labelled anti-human CD69 antibody (B and D, right panel) or a similarly labelled isotype control antibody 
(B and D, left panel). Cells from the HIV negative donor (HIV-) were used in (A) and (B), and cells from the HIV-1-infected 
donor (HIV+) were used in (C) and (D).
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example, cofilin was shown to affect SDF1α-driven T cell
chemotaxis, and blocking cofilin phosphorylation dimin-
ishes actin reorganization and normal chemotactic
response [9]. During T cell activation, cofilin is activated
by co-stimulation signals to mediate cortical actin reor-
ganization, which plays a critical role in the formation
and stabilization of the immunological synapse. It is com-
monly known that genetic defects affecting actin activity
by means of a deficiency in signaling molecules, such as
WASP, cause immunodeficiency [31,32]. It would not be
a surprise if cofilin dysregulation also results in T cell-
mediated immunodeficiencies, given the central role of
cofilin in regulating actin dynamics in T cells [33].
The demonstration of cofilin activation in resting CD4 T
cells of HIV-1-infected patients offers new avenues for
investigation into viral pathogenesis. It has long been rec-
ognized that the residual CD4 T cells in HIV-1-infected
patients have numerous functional abnormalities, such as
loss of T helper function [34], T cell anergy [35,36],
increased T cell proliferation [37] and abnormal T cell
homing and migration [38,39]. These T cell defects largely
result from a bystander effect [40]. It remains to be deter-
mined whether some of these abnormalities are directly
linked to aberrant activation of cofilin in resting CD4 T
cells. Additionally, as shown in this pilot study, the
peripheral CD4 T cells in HIV-1 patients strikingly resem-
ble the migratory T lymphoma cells in terms of carrying
active cofilin [21,41]. It is likely that these CD4 T cells also
have abnormal migratory behaviours associated with
aberrant cofilin activation. It remains unknown whether
migratory abnormalities could contribute to the eventual
destruction of T cells in lymph nodes or tissues. Finally,
the identification of cofilin as a critical molecule in resting
CD4 T cells of infected patients may serve as a diagnostic
marker to reflect alterations of T cell function in disease
progression.
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